Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Find out which travel credit cards without fees provide the most rewarding experiences for your travels.
26,586 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Gen Z is departing San Francisco for Texas and Florida, triggering a new wave where welcomer cities like Nashville an...
Looking for steady income from your investments? Explore two industrial stocks growing dividends that blend resilienc...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
A Rotterdam court faces a dramatic move as prosecutors seek bankrupt status for the Knaken exchange after user funds ...
Micron stock surged last month on AI memory demand and strong results, then faced a July pullback as traders reassess...
Starting with $1,000, you can build a dependable dividend-focused plan. Learn what makes the smartest dividend stock ...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
GLP-1 drugs like Ozempic and Wegovy are changing the cost landscape for retirees. This guide breaks down what Medicar...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Two dividend-focused ETFs have stood out lately, offering steady income and solid returns. This guide breaks down why...